Chinese pharmaceutical company founded in 1990 with headquarters in Xinchang county and Hangzhou, Zhejiang, listed on the Shenzhen Stock Exchange under code 002020. Runs six production bases in Xinchang and Shangyu in Zhejiang, Guangfeng in Jiangxi, Bayannur in Inner Mongolia, Shenzhen and Shenyang, plus a research centre in the Zhangjiang high-tech park in Shanghai, with close to 3,000 staff, 736 million yuan of registered capital and around 4.5 billion yuan of total assets. Develops, manufactures and sells chemical formulations, traditional Chinese medicines, biologics, active pharmaceutical ingredients and medical devices, aiming to lead in Chinese psychiatric, neurological and cardio-cerebrovascular medicine. A national key high-tech enterprise with a national technology centre, academician workstation and postdoctoral research station, holding eight national key new products and nine national Torch Programme projects.
Leave your rating